Streamlining Dermatology Fax & Paper Form Automation for Prior Authorizations

Klivira delivers advanced dermatology fax & paper form automation, transforming labor-intensive prior authorization processes into efficient, digital workflows for dermatology practices.

For dermatology practices, the persistence of fax and paper forms for prior authorizations remains a significant operational bottleneck, particularly for high-volume biologics and procedures. Klivira addresses these long-tail payer fax workflows by digitizing and automating submissions, freeing up PA coordinators and accelerating patient access to critical treatments.

The Challenge of Manual Fax & Paper in Dermatology PA

Despite advancements in electronic prior authorization (ePA), many payers continue to mandate fax or paper submissions for specific dermatology treatments and procedures. This manual burden, from form identification and data entry to submission and tracking, diverts staff from patient care and introduces delays, especially for complex cases like biologic therapies and Mohs surgery.

Key Dermatology PA Triggers Requiring Fax & Paper Automation

Biologics for psoriasis and psoriatic arthritis (e.g., Dupixent, Cosentyx, Tremfya, Skyrizi, Humira, Enbrel)
Biologics for atopic dermatitis (e.g., dupilumab/Dupixent, tralokinumab/Adbry)
Hidradenitis suppurativa biologics (e.g., adalimumab/Humira)
Mohs micrographic surgery, particularly for non-melanoma skin cancers in cosmetically sensitive areas
Advanced skin cancer treatments and specific phototherapy regimens
Periodic re-authorization for chronic biologic treatments

Automating Documentation & Guideline Adherence for Fax Submissions

Dermatology prior authorizations are heavily reliant on detailed clinical documentation, often guided by AAD Clinical Guidelines and NCCN for skin cancers. Klivira's automation platform leverages intelligent OCR and form-filling capabilities to extract and populate required data from EMRs into payer-specific fax forms, ensuring compliance with step therapy protocols, disease severity scores (PASI, EASI, BSA), and Mohs Appropriate Use Criteria (AUC).

Addressing Common Denial Reasons Through Automation

Automated verification of documented step therapy compliance for psoriasis biologics, reducing denials for failure to trial conventional therapies.
Ensuring Mohs AUC conformance is clearly presented on forms to mitigate site or tumor type mismatches.
Validating the presence of documented disease severity (PASI, EASI, BSA scores) before submission.
Flagging missing pre-biologic screenings (TB, hepatitis) to prevent rejections.
Streamlining the re-authorization process for chronic biologic treatments to avoid coverage lapses.

Klivira’s Integrated Approach to Dermatology Fax Automation

Klivira integrates seamlessly with your EMR to capture necessary clinical data, then intelligently processes and submits prior authorization requests to payers that still require fax or paper forms. Our platform manages the entire lifecycle, from initial submission to follow-up, providing visibility and audit trails for all communications, regardless of the payer's preferred channel.

Operational Benefits for Dermatology Practices

Implementing Klivira's dermatology fax & paper form automation translates directly to tangible operational efficiencies. Practices experience reduced administrative overhead, faster turnaround times for prior authorizations, and improved first-pass approval rates. This allows PA coordinators to focus on complex cases and patient advocacy, ultimately enhancing patient access to essential dermatological care and improving revenue cycle performance.

Frequently asked questions

How does Klivira handle the specific documentation for biologics like Dupixent or Skyrizi via fax?

Klivira's platform is configured to recognize and extract the specific clinical data points required for biologic prior authorizations, such as PASI/BSA scores, EASI/SCORAD, and documented trials of prior therapies. This data is then accurately populated into the correct payer-specific fax forms, ensuring all necessary criteria are met for submission.

Can Klivira automate Mohs surgery prior authorizations that require fax submissions?

Yes, Klivira automates Mohs surgery prior authorizations, including those requiring fax submissions. Our system validates against Mohs Appropriate Use Criteria (AUC) and ensures that the required site, tumor type, and other relevant details are correctly entered and submitted on the payer's specific forms.

How does Klivira integrate with our EMR to pull data for fax forms?

Klivira integrates with your EMR via secure, standards-based protocols to pull relevant patient demographics, clinical notes, and treatment histories. This data is then used to pre-populate prior authorization forms, minimizing manual data entry and ensuring data accuracy before fax submission.

What happens after a faxed prior authorization is sent through Klivira?

After a faxed prior authorization is sent via Klivira, the platform provides a digital record of the submission, including confirmation. It also facilitates tracking and follow-up, allowing your team to monitor the status of the request and receive updates, streamlining the entire communication process with the payer.

Does Klivira manage re-authorizations for chronic dermatology conditions like psoriasis?

Absolutely. Klivira supports the management of periodic re-authorizations for chronic dermatology conditions. The system can flag upcoming re-authorization needs, pre-populate forms with updated clinical information, and automate the re-submission process, helping to prevent gaps in patient coverage.